<DOC>
	<DOCNO>NCT02022722</DOCNO>
	<brief_summary>The purpose study evaluate treatment option pelvic floor pain allow improve sexual function .</brief_summary>
	<brief_title>Trigger Point Injections Pelvic Rehabilitation Treatment Pelvic Floor Myalgia Sexual Pain</brief_title>
	<detailed_description>Pelvic floor pain may treat trigger point injection medication ( steroid local anesthetic ) FDA approve injection muscle . The alternative noninvasive treatment option use pelvic rehabilitation involve vaginal muscle massage . Both treatment option use report ; however , rapidity improvement return normal sexual function assess . This study assign patient either treatment option randomly sexual function assess base standardized sexual function questionnaire well pain rating .</detailed_description>
	<mesh_term>Dyspareunia</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>pelvic pain pelvic floor myalgia dyspareunia female age &gt; 18 year interstitial cystitis vaginal lesion / ulceration prior trigger point injection past 6 month prior pelvic rehabilitation past 6 month laparoscopically document endometriosis / pelvic adhesion adhesive disease document pelvic inflammatory disease identify within past 6 month document sexually transmitted disease within past 6 month</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Pelvic Floor Myalgia</keyword>
	<keyword>Trigger Point Injections</keyword>
	<keyword>Pelvic Rehabilitation</keyword>
	<keyword>Dyspareunia</keyword>
</DOC>